New Metrics from Polysomnography: Precision Medicine for OSA Interventions

Junwei Guo,Yi Xiao

DOI: https://doi.org/10.2147/NSS.S400048

2023-03-09

Nature and Science of Sleep

Abstract:Junwei Guo, Yi Xiao Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China Correspondence: Yi Xiao, Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730, People's Republic of China, Tel +86 010 69155037, Email Obstructive sleep apnea (OSA) is a highly preventable disease accompanied by multiple comorbid conditions. Despite the well-established cardiovascular and neurocognitive sequelae with OSA, the optimal metric for assessing the OSA severity and response to therapy remains controversial. Although overnight polysomnography (PSG) is the golden standard for OSA diagnosis, the abundant information is not fully exploited. With the development of deep learning and the era of big data, new metrics derived from PSG have been validated in some OSA consequences and personalized treatment. In this review, these metrics are introduced based on the pathophysiological mechanisms of OSA and new technologies. Emphasis is laid on the advantages and the prognostic value against apnea-hypopnea index. New classification criteria should be established based on these metrics and other clinical characters for precision medicine. Keywords: obstructive sleep apnea, precision medicine, polysomnography, metrics Obstructive sleep apnea (OSA) is a chronic disease affecting almost one billion people around the world. 1 It is characterized by partial or complete upper airway collapse during sleep, leading to sleep fragmentation and intermittent hypoxemia. The consequences brought by OSA include disturbance of sleep structure, daytime sleepiness, various complications and decreased quality of life. Studies have revealed that the economic burden of OSA is substantial. 2 The metric used for evaluating OSA severity is the apnea-hypopnea index (AHI), which mainly describes the frequency of respiratory events. Despite its convenience and wide acceptance, several defects remain which oversimplify the complexity of OSA and lead to the poor correlation with OSA consequences. First, the definition of AHI treats apnea and hypopnea equivalently. The severity of airway obstruction is associated with degree of desaturation and arousals. Studies have demonstrated that OSA patients with different respiratory patterns presented different disease severity. 3 The predominance of apnea or hypopnea could be a potential subtype correlated with certain OSA comorbidity. Second, the different rules for hypopnea definition in clinical practice may bring inconsistencies to the diagnosis and severity evaluation of OSA, leaving some asymptomatic OSA patients untreated. 4 The association of OSA with comorbidities using different criteria could be discrepant. 5 Another nonnegligible issue is that AHI does not directly reflect the pathogenesis of OSA. Other auxiliary metrics like lowest pulse oxygen saturation (LSpO 2 ), percentage time below 90% oxygen saturation (T90) and oxygen desaturation index (ODI) evaluate event-related desaturation from a single aspect but have not been recommended as the diagnostic criteria. Degree, duration of desaturation, respiratory event duration, and intensity of arousals could all represent certain aspects of OSA pathophysiology, yet none of them are integrated in AHI. These defects could be the reasons for poor relationship between OSA and relevant comorbidities. 6,7 Furthermore, the adherence of continuous positive airway pressure (CPAP), the primary therapy, is relatively low. In some cases, CPAP showed an insignificant effect on OSA comorbidities while CPAP tends to be the one-size-fits-all therapy for OSA. 8,9 Since the term of polysomnography (PSG) was first created in 1974, 10 it has been applied as the golden standard diagnostic examination for OSA. A typical overnight PSG examination contains plenty of biological signals such as electroencephalogram (EEG), electrooculogram, nasal airflow, electromyogram, electrocardiogram (ECG), respiratory effort and blood oxygen. These simultaneously recorded signals can provide a great deal of information on patients' sleeping, respiratory and cardiovascular status. Apart from the original signals, data generated by advanced technologies like machine learning can further identify certain subgroups of patients who may benefit from personalized treatment. Moreover, efforts have been made to establish large data sets for researchers. Online resources like the National Sleep Research Resource 11 and PhysioNet 12 have thousands of PSG recordings which offer the o -Abstract Truncated-

neurosciences,clinical neurology